Almizraq Ruqayyah J, Seghatchian Jerard, Holovati Jelena L, Acker Jason P
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada T6G 2R8.
International Consultancy in Blood Component Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK.
Transfus Apher Sci. 2017 Apr;56(2):254-260. doi: 10.1016/j.transci.2017.03.007. Epub 2017 Mar 9.
Extracellular vesicles (EVs), including microvesicles and exosomes, are small phospholipid vesicles (≤1μm in diameter) that are present in blood products, accumulate during storage, and have a potential transfusion-related immunomodulatory role. Knowledge of EVs in stored blood products is limited due to the challenges and difficulties in detecting these heterogeneous submicron-sized vesicles. The aim of this study was to assess the impact of different approaches to characterize EVs in stored RBC products. Quantification and size-profiling of EVs in leukoreduced red cell concentrates (RCCs) were examined on day 3, 7, 21, and 42 of storage using tunable resistive plus sensing (TRPS), flow cytometer (FC), and dynamic light scatting (DLS) methods. Using the TRPS method, the concentration of EVs<200nm significantly increased throughout storage (p<0.05). This change in exosome concentration was not detectable with FC or DLS due to limitations in their ability to resolve particles <200nm and/or accurately determine EV concentration. Both the TRPS and FC demonstrate that the concentration of EVs≥200nm significantly increases in RCCs by day 42/43 compared to EVs present on day 3 (p<0.001). As the DLS measures the average size of particles in suspension, only an increase in the zeta-average size was observed during storage. EV size and concentration in RBC products is significantly influenced by the length of storage. Overall, this study shows that combining technologies may be important to improve the characterization and study of EVs in stored RCCs.
细胞外囊泡(EVs),包括微囊泡和外泌体,是存在于血液制品中的小磷脂囊泡(直径≤1μm),在储存过程中会积累,并且具有潜在的输血相关免疫调节作用。由于检测这些异质性亚微米大小囊泡存在挑战和困难,关于储存血液制品中细胞外囊泡的知识有限。本研究的目的是评估不同方法对储存红细胞制品中细胞外囊泡进行表征的影响。在储存的第3天、第7天、第21天和第42天,使用可调电阻脉冲传感(TRPS)、流式细胞仪(FC)和动态光散射(DLS)方法检测去白细胞红细胞浓缩液(RCCs)中细胞外囊泡的定量和大小分布。使用TRPS方法,直径<200nm的细胞外囊泡浓度在整个储存过程中显著增加(p<0.05)。由于流式细胞仪和动态光散射技术在分辨<200nm颗粒和/或准确测定细胞外囊泡浓度方面存在局限性,因此无法检测到外泌体浓度的这种变化。TRPS和流式细胞仪均表明,与第3天存在的细胞外囊泡相比,到第42/43天时,RCCs中直径≥200nm的细胞外囊泡浓度显著增加(p<0.001)。由于动态光散射测量悬浮液中颗粒的平均大小,因此在储存过程中仅观察到zeta平均大小增加。红细胞制品中细胞外囊泡的大小和浓度受储存时间的显著影响。总体而言,本研究表明,结合多种技术对于改善储存RCCs中细胞外囊泡的表征和研究可能很重要。